Cargando…

Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma

Ovarian clear cell carcinomas (OCCCs) are resistant to conventional anti-cancer drugs; moreover, the prognoses of advanced or recurrent patients are extremely poor. OCCCs often arise from endometriosis associated with strong oxidative stress. Of note, the stress involved in OCCCs can be divided into...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amano, Tsukuru, Murakami, Atsushi, Murakami, Takashi, Chano, Tokuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911626/ https://www.ncbi.nlm.nih.gov/pubmed/33525614 http://dx.doi.org/10.3390/antiox10020187

Ejemplares similares

Current Position of the Molecular Therapeutic Targets for Ovarian Clear Cell Carcinoma: A Literature Review
por: Amano, Tsukuru, et al.
Publicado: (2019)

Abundance of mitochondrial superoxide dismutase is a negative predictive biomarker for endometriosis-associated ovarian cancers
por: Amano, Tsukuru, et al.
Publicado: (2019)

Therapeutic inhibition of mitochondrial function induces cell death in starvation-resistant renal cell carcinomas
por: Isono, Takahiro, et al.
Publicado: (2016)

The target therapy of ovarian clear cell carcinoma
por: Jin, Ying, et al.
Publicado: (2014)

Severe hydronephrosis secondary to uterine artery pseudoaneurysm in the early second trimester of pregnancy: A case report
por: Amano, Tsukuru, et al.
Publicado: (2017)

Acquired Evolution of Mitochondrial Metabolism Regulated by HNF1B in Ovarian Clear Cell Carcinoma
por: Yamaguchi, Ken, et al.
Publicado: (2021)

Updates of Pathogenesis, Diagnostic and Therapeutic Perspectives for Ovarian Clear Cell Carcinoma
por: Zhu, Chenchen, et al.
Publicado: (2021)

Prevalence, definition, and etiology of cesarean scar defect and treatment of cesarean scar disorder: A narrative review
por: Tsuji, Shunichiro, et al.
Publicado: (2023)

Glucose Deprivation Induces G2/M Transition-Arrest and Cell Death in N-GlcNAc(2)-Modified Protein-Producing Renal Carcinoma Cells
por: Isono, Takahiro, et al.
Publicado: (2014)

A novel surgical treatment for labial adhesion – The combination of Z- and Y-V-plasty: A case report
por: Maeda, Tomoko, et al.
Publicado: (2021)

Study of Global Transcriptional Changes of N-GlcNAc(2) Proteins-Producing T24 Bladder Carcinoma Cells under Glucose Deprivation
por: Isono, Takahiro, et al.
Publicado: (2013)

c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma
por: Kim, Ha-Jeong, et al.
Publicado: (2016)

Correction: Study of Global Transcriptional Changes of N-GlcNAc(2) Proteins-Producing T24 Bladder Carcinoma Cells under Glucose Deprivation
por: Isono, Takahiro, et al.
Publicado: (2013)

Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas
por: Shoji, Tadahiro, et al.
Publicado: (2021)

Therapeutic Strategies Focused on Cancer-Associated Hypercoagulation for Ovarian Clear Cell Carcinoma
por: Tamura, Ryo, et al.
Publicado: (2022)

Successful conservative treatment for massive uterine bleeding with non-septic disseminated intravascular coagulation after termination of early pregnancy in a woman with huge adenomyosis: case report
por: Kimura, Fuminori, et al.
Publicado: (2020)

Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers
por: Stany, Michael P., et al.
Publicado: (2011)

Ovarian Seromucinous Borderline Tumor and Clear Cell Carcinoma: An Unusual Combination
por: Nakamura, Eriko, et al.
Publicado: (2015)

Ovarian cancer: new developments in clear cell carcinoma and hopes for targeted therapy
por: Yamashita, Yoriko
Publicado: (2015)

Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives
por: Matsuzaki, Shinya, et al.
Publicado: (2015)

Treatment Strategies for ARID1A-Deficient Ovarian Clear Cell Carcinoma
por: Takahashi, Kazuaki, et al.
Publicado: (2021)

Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma
por: Abou-Taleb, Hisham, et al.
Publicado: (2016)

Frequent PIK3CA mutations in eutopic endometrium of patients with ovarian clear cell carcinoma
por: Murakami, Kosuke, et al.
Publicado: (2021)

Locally advanced endometrial cancer with multiple immune-related adverse events coinciding with the complete response to radiotherapy after immune checkpoint inhibitor therapy: A case report
por: Tanaka, Yuji, et al.
Publicado: (2023)

Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas
por: Miyamoto, Morikazu, et al.
Publicado: (2017)

Abundance of TRAIL attenuated by HIF2α and c-FLIP affects malignancy in renal cell carcinomas
por: Isono, Takahiro, et al.
Publicado: (2018)

Pregnancy outcomes after hysteroscopic surgery in women with cesarean scar syndrome
por: Tsuji, Shunichiro, et al.
Publicado: (2020)

Ovarian clear cell carcinoma meets metabolism; HNF-1β confers survival benefits through the Warburg effect and ROS reduction
por: Mandai, Masaki, et al.
Publicado: (2015)

PDK2 leads to cisplatin resistance through suppression of mitochondrial function in ovarian clear cell carcinoma
por: Kitamura, Sachiko, et al.
Publicado: (2021)

Clear cell carcinoma of the seminal vesicle in a young adult
por: Murakami, Hidetoshi, et al.
Publicado: (2022)

Therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma
por: Yamazaki, Hiroyuki, et al.
Publicado: (2018)

Cancer-Specific miRNAs Extracted from Tissue-Exudative Extracellular Vesicles in Ovarian Clear Cell Carcinoma
por: Maruoka, Hiroshi, et al.
Publicado: (2022)

Targeting DNA Damage Response Pathway in Ovarian Clear Cell Carcinoma
por: Wong, Oscar G. W., et al.
Publicado: (2021)

New perspectives on molecular targeted therapy in ovarian clear cell carcinoma
por: Tan, D S P, et al.
Publicado: (2013)

CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma
por: Kawahara, Naoki, et al.
Publicado: (2021)

An abdominal-sacral approach with preoperative embolisation for vulvar solitary fibrous tumour: a case report
por: Takahashi, Akimasa, et al.
Publicado: (2021)

Histopathological evaluation of cesarean scar defect in women with cesarean scar syndrome
por: Higuchi, Asuka, et al.
Publicado: (2021)

Identification and Validation of Housekeeping Genes for Gene Expression Analysis of Cancer Stem Cells
por: Lemma, Silvia, et al.
Publicado: (2016)

The histone methyltransferase SMYD2 is a novel therapeutic target for the induction of apoptosis in ovarian clear cell carcinoma cells
por: Kojima, Machiko, et al.
Publicado: (2020)

Endometriosis-associated Ovarian Clear Cell Carcinoma: A Special Entity?
por: Sun, Yue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h80tlbtmlviid2a0ng2p6ekr1b